
Re: [新聞] 增3死、中重症+21 「女嬰發燒送加護」妙齡女打三劑居家照護突惡化已回收

: 人家國外是確診就給口服藥
: 台灣只有清冠一號
哪個國家是一確診就給paxlovid
說來聽聽吧
我準備好資料要來打你臉了
: 這種條件還敢跟國外一樣搞共存
: 我也只能呵呵…
: 當年我兒子燒個不停,醫生只是懷疑得流感,就立刻開克流感
: 怎麼現在確診Covid-19 ,就只是待在家裡,吃清冠一號!?
: 超前部署?
: 去年爆發沒疫苗,拖到果凍看不下去,跟台積電、慈濟聯合掏腰包買BNT,外國還捐了
一
: 堆AZ給我們,美國爸爸也捐了莫德納
: 今年爆發沒口服藥、快篩,是不是又要拖到民間看不下去、拖到美國爸爸、日本哥哥看
不
: 下去!?
: 台灣的臉都被丟光了!還敢講「看好了世界,台灣只示範一次」、「Taiwan can help
」
: 自求多福吧…各位台灣同胞…
: 自己選的,自己承擔
: 四個不同意,共存更給力
依照用藥說明書載明,該藥與多種心臟血管用藥、止痛藥、抗癌藥、抗凝血藥、抗痙攣藥
、抗憂鬱或精神病劑、抗痛風藥、HIV與C型肝炎等抗病毒劑、抗感染劑、荷爾蒙避孕藥、
免疫抑制劑、麻醉、鎮靜或安眠藥,以及全身性類固醇等藥品會產生交互作用。
一確診就無腦給Paxlovid
然後遇到上面說的對象
責任算誰的?
說看看啊
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 101.12.42.125 (臺灣)
※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1651489873.A.577.html
推
05/02 19:16,
3年前
, 1F
05/02 19:16, 1F
笑死 這根本不是政府的文章
→
05/02 19:16,
3年前
, 2F
05/02 19:16, 2F
→
05/02 19:18,
3年前
, 3F
05/02 19:18, 3F
5. Can anyone get a Paxlovid prescription?
The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88
pounds. But in order to qualify for a prescription, you must also have had a
positive COVID-19 test result and be at high risk for developing severe COVID-
19.
That means you must either have certain underlying conditions (including cance
r, diabetes, obesity, or others) or be 65 or older (more than 81% of COVID-19
deaths occur in in this group). The more underlying medical conditions a perso
n has, the higher their risk for developing a severe case of COVID-19, accordi
ng to the CDC.
並不是你說的篩陽就給藥喔 英文不太好?
推
05/02 19:18,
3年前
, 4F
05/02 19:18, 4F
→
05/02 19:18,
3年前
, 5F
05/02 19:18, 5F
英國這做法合理,但仍然不夠安全
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:19:20
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:22:44
推
05/02 19:24,
3年前
, 6F
05/02 19:24, 6F
→
05/02 19:24,
3年前
, 7F
05/02 19:24, 7F
→
05/02 19:25,
3年前
, 8F
05/02 19:25, 8F
→
05/02 19:25,
3年前
, 9F
05/02 19:25, 9F
→
05/02 19:26,
3年前
, 10F
05/02 19:26, 10F
Before prescribing ritonavir-boosted nirmatrelvir, clinicians should carefully
review the patient’s concomitant medications, including over-the-counter med
ications, herbal supplements, and recreational drugs, to evaluate potential dr
ug-drug interactions.
看來你英文真的不好
→
05/02 19:26,
3年前
, 11F
05/02 19:26, 11F

→
05/02 19:26,
3年前
, 12F
05/02 19:26, 12F

→
05/02 19:27,
3年前
, 13F
05/02 19:27, 13F
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:27:50
→
05/02 19:27,
3年前
, 14F
05/02 19:27, 14F
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:28:23
→
05/02 19:28,
3年前
, 15F
05/02 19:28, 15F
推
05/02 19:29,
3年前
, 16F
05/02 19:29, 16F
所以有篩陽就給藥嗎?
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:30:18
→
05/02 19:30,
3年前
, 17F
05/02 19:30, 17F
→
05/02 19:30,
3年前
, 18F
05/02 19:30, 18F
→
05/02 19:30,
3年前
, 19F
05/02 19:30, 19F
→
05/02 19:30,
3年前
, 20F
05/02 19:30, 20F
→
05/02 19:31,
3年前
, 21F
05/02 19:31, 21F
→
05/02 19:31,
3年前
, 22F
05/02 19:31, 22F
→
05/02 19:31,
3年前
, 23F
05/02 19:31, 23F
推
05/02 19:33,
3年前
, 24F
05/02 19:33, 24F
→
05/02 19:33,
3年前
, 25F
05/02 19:33, 25F
→
05/02 19:33,
3年前
, 26F
05/02 19:33, 26F
CONTRAINDICATIONS
History of clinically significant hypersensitivity reactions to the active ing
redients (nirmatrelvir or ritonavir) or any other components. (4) ‧ Co-admini
stration with drugs highly dependent on CYP3A for clearance and for which elev
ated concentrations are associated with serious and/or life-threatening reacti
ons. (4, 7.3) ‧ Co-administration with potent CYP3A inducers where significan
tly reduced nirmatrelvir or ritonavir plasma concentrations may be associated
with the potential for loss of virologic response and possible resistance.
WARNINGS AND PRECAUTIONS
The concomitant use of PAXLOVID and certain other drugs may result in potentia
lly significant drug interactions. Consult the full prescribing information pr
ior to and during treatment for potential drug interactions. (5.1, 7) ‧ Aller
gic Reactions/Hypersensitivity: Hypersensitivity reactions have been reported
with PAXLOVID. If signs and symptoms of a clinically significant hypersensitiv
ity reaction or anaphylaxis occur, immediately discontinue PAXLOVID and initia
te appropriate medications and/or supportive care. (5.2) ‧ Hepatotoxicity: He
patic transaminase elevations, clinical hepatitis, and jaundice have occurred
in patients receiving ritonavir. (5.3) ‧ HIV-1 Drug Resistance: PAXLOVID use
may lead to a risk of HIV-1 developing resistance to HIV protease inhibitors i
n individuals with uncontrolled or undiagnosed HIV-1 infection. (5.4)
打臉打到手有點酸
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:37:30
推
05/02 19:36,
3年前
, 27F
05/02 19:36, 27F
看來你真的看不懂英文XD
→
05/02 19:38,
3年前
, 28F
05/02 19:38, 28F
→
05/02 19:39,
3年前
, 29F
05/02 19:39, 29F
根本沒有篩陽就給藥這事情
都要先審視用藥者的狀況
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:40:24
→
05/02 19:40,
3年前
, 30F
05/02 19:40, 30F
→
05/02 19:40,
3年前
, 31F
05/02 19:40, 31F
→
05/02 19:41,
3年前
, 32F
05/02 19:41, 32F
推
05/02 19:44,
3年前
, 33F
05/02 19:44, 33F
※ 編輯: Croy (101.12.42.125 臺灣), 05/02/2022 19:44:26
→
05/02 19:44,
3年前
, 34F
05/02 19:44, 34F
→
05/02 19:45,
3年前
, 35F
05/02 19:45, 35F
→
05/02 19:46,
3年前
, 36F
05/02 19:46, 36F
→
05/02 19:47,
3年前
, 37F
05/02 19:47, 37F
→
05/02 19:48,
3年前
, 38F
05/02 19:48, 38F

→
05/02 19:48,
3年前
, 39F
05/02 19:48, 39F
→
05/02 19:50,
3年前
, 40F
05/02 19:50, 40F
→
05/02 19:50,
3年前
, 41F
05/02 19:50, 41F
→
05/02 19:50,
3年前
, 42F
05/02 19:50, 42F
→
05/02 19:50,
3年前
, 43F
05/02 19:50, 43F
→
05/02 19:50,
3年前
, 44F
05/02 19:50, 44F
推
05/02 19:51,
3年前
, 45F
05/02 19:51, 45F
→
05/02 19:51,
3年前
, 46F
05/02 19:51, 46F
→
05/02 19:52,
3年前
, 47F
05/02 19:52, 47F
→
05/02 19:52,
3年前
, 48F
05/02 19:52, 48F
→
05/02 19:53,
3年前
, 49F
05/02 19:53, 49F
→
05/02 19:53,
3年前
, 50F
05/02 19:53, 50F
→
05/02 19:54,
3年前
, 51F
05/02 19:54, 51F
→
05/02 19:54,
3年前
, 52F
05/02 19:54, 52F
→
05/02 19:55,
3年前
, 53F
05/02 19:55, 53F
推
05/03 09:55,
3年前
, 54F
05/03 09:55, 54F
→
05/03 09:56,
3年前
, 55F
05/03 09:56, 55F
討論串 (同標題文章)
本文引述了以下文章的的內容:
完整討論串 (本文為第 3 之 3 篇):